SARITHA SANDRA D’SOUZA, PHD
Present Research: My research in the lab is focused on establishing a culture system that induces hematopoietic cell differentiation from Cynomolgus monkey iPSCs. In addition I am also working on the functional heterogeneity of human pluripotent stem cell derived endothelial progenitors.
Educational background: I completed my PhD from the University of Mysore, Karnataka, India in 2011. My doctoral work was focused on the regulation of tumor angiogenesis by angiopoietins. Part of my doctoral research work was completed in the Pediatric Oncology laboratory, University Hospital, Freiburg, Germany, wherein I worked on RNA interference technique to silence Angiopoietin 2 and its subsequent effect on neuroblastoma progression. The work also included drug-based therapy against angiopoietins in a xenograft model of neuroblastoma.
Personal Info: I celebrate my birthday on the 8th of January along with my husband. I moved to Madison with my small family in 2011. Having lived in India, Germany and now in USA I have mastered the skill to communicate in 6 languages, though my German is no good at all. I love to dance, travel and I am looking forward to good memories here in the USA.
HO SUN JUNG, PHD
Research Interests: site specific integration using ZFN and CRISPR in Human Embryonic Stem cell
BS – Inje University, South Korea
MS – Hanyang University, South Korea
PhD – Yonsei Univeisiry, South Korea
AKHILESH KUMAR, PHD
Akhilesh received his PhD (2011) for Molecular studies on the Regulation of Osteogenic Differentiation of Mesenchymal Stem Cells (MSCs) and Tumor angiogenesis. He was awarded DAAD scholarship to do research at Universitat klinikum, Freiburg, Germany. He then joined Slukvin’s lab where he develops various vasculogenic and multipotent cells from hPSC, which can provide all essential components of the vasculature and may be a scalable source of the entire spectrum of cells required for therapeutic vascular tissue engineering. Later he studied the angiogenic potential of hPSC derived endothelial progenitor cells. Currently he’s working on generation of hPSC derived T cells to provide invaluable sources for immune cell therapies. When not in lab, he enjoys spending time with family, watching TV series on Netflix. Akhilesh is a huge fan of Indian cricket and American football!
ADITI MAJUMDER, Ph.D
B.Sc (2010): University of Calcutta, India
M.Sc (2012): Jadavpur University, India
Ph.D (2020): Rajiv Gandhi Centre for Biotechnology, Manipal University, India
Research Interest: Generation of different types of blood cells from human induced pluripotent stem cells using modified mRNA for immunotherapy.
Personal Information: I love to enjoy music and traveling. My special interest is to learn different genre of music.
I am a PhD student in the Comparative Biomedical Sciences program in the School of Veterinary Medicine. My research project focuses on utilizing human pluripotent stem cells (hPSCs) to differentiate functional macrophages and other innate immune cells to explore potential anti-tumor cellular immunotherapies.
KRAN SUKNUNTHA, MD, PHD
Education: 2013 Ph.D., University of Wisconsin, Madison, USA
2007 M.D., Ramathibodi Hospital, Mahidol University, Thailand
My researches focus on the generation of human-induced pluripotent stem cells (iPSCs) and its application. Currently, I am working on a chronic myeloid leukemia iPSCs (CML iPSCs) established from our group. Interestingly, we found hematopoietic cells, specifically CD34+, generated from CML iPSCs (iCD34+) demonstrate features of somatic CML stem cell. I perform RNA sequencing on iCD34+ generated from normal and CML iPSCs to screen for a new drug target and further validate if such targets have clinical usage potential.
NICK STRELCHENKO, PHD
I received my PhD in somatic cell genetics in an animal genetics laboratory at the Institute of General Genetics Academy Science USSR in Moscow. My major scientific interest is in stem cell reprogramming. My previous work involved a novel cloning project at the American Breeders Service that was successfully completed in 1997. Later, I began work with human ES-cell lines at the Reproductive Genetics Institute in Chicago, where over 80 ES-cell lines derived from genetically affected embryos were established. I recently joined the Slukvin lab to develop a novel model of bone marrow transplantation in non-human primates.
Matt Raymond, BS, MS